On May 22, Supernus Pharmaceuticals Inc (NASDAQ:SUPN) announced that it has received a milestone payment of $2 million from partner United Therapeutics Corp. for the launch of Orenitram (treprostinil) extended-release tablets. Supernus will also receive royalties on net sales of Orenitram and additional payments on the achievement of certain milestones. Supernus Pharmaceuticals Inc (NASDAQ:SUPN) weekly performance is 2.68%. On last trading day company shares ended up $10.74. Analysts mean target price for the company is $12.30. Supernus Pharmaceuticals Inc (NASDAQ:SUPN)distance from 50-day simple moving average (SMA50) is 24.24%.
On June 18, Levi & Korsinsky, LLP is investigating Molina Healthcare, Inc. (NYSE:MOH)in connection with possible claims of breaches of fiduciary duty by certain members of the board of directors of the Company. Molina Healthcare, Inc. (NYSE:MOH) shares fell -0.98% in last trading session and ended the day on $45.33. MOH Gross Margin is 97.70% and its return on assets is 0.90%. Molina Healthcare, Inc. (NYSE:MOH) quarterly performance is 19.13%.
)n June 2, Theravance Inc and Theravance Biopharma Inc (NASDAQ:TBPH): Say completion of separation of Theravance Biopharma Inc, research and development-based biopharmaceutical business, from Theravance Inc to form two, independent, publicly traded companies with differing business objectives and opportunities.Separation is achieved via a dividend distribution of Theravance Biopharma shares to Theravance stockholders. Theravance Biopharma Inc (NASDAQ:TBPH) shares moved up 1.40% in last trading session and was closed at $34.87, while trading in range of $33.16 – $35.24. Theravance Biopharma Inc (NASDAQ:TBPH) year to date (YTD) performance is 51.87%.
On June 18, Humana Inc (NYSE:HUM), has been ranked among America’s greenest companies by Newsweek magazine for its corporate sustainability and environmental sustainability endeavors. Rising to No. 69 on Newsweek’s rankings, Humana was the highest ranked health insurer and No. 10 out of all health care companies on the 500-company list. Humana Inc (NYSE:HUM) ended the last trading day at $127.32. Company weekly volatility is calculated as 1.40%and price to cash ratio as 1.99. Humana Inc (NYSE:HUM) showed a positive weekly performance of 3.47%.